Kowa Pharmaceuticals America, Inc., is committed to continuing the development and commercialization of safe, effective healthcare solutions.
Kowa Pharmaceuticals America, Inc., will be at Booth 202 and is sponsoring a Product Theater about the first and only multimodal co-crystal for the treatment of acute pain in appropriate patients designed to highlight key background about acute pain management as well as clinical information, such as Important Safety Information, including Boxed Warning, dosing and administration, safety, and efficacy, from the pivotal Phase III clinical trial.
This product theater is independent of PainWeek®. This program is not certified for CE/CME.